These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24234332)

  • 21. Expression of cdc25B and cdc25A in medullary thyroid carcinoma: cdc25B expression level predicts a poor prognosis.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Nakamura Y; Kakudo K; Miyauchi A
    Cancer Lett; 2005 Nov; 229(2):291-7. PubMed ID: 16095809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
    Su Y; Qiu Q; Zhang X; Jiang Z; Leng Q; Liu Z; Stass SA; Jiang F
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):327-37. PubMed ID: 20142235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Bmi-1 is a prognostic marker in bladder cancer.
    Qin ZK; Yang JA; Ye YL; Zhang X; Xu LH; Zhou FJ; Han H; Liu ZW; Song LB; Zeng MS
    BMC Cancer; 2009 Feb; 9():61. PubMed ID: 19228380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
    Boman K; Segersten U; Ahlgren G; Eberhard J; Uhlén M; Jirström K; Malmström PU
    BMC Urol; 2013 Apr; 13():17. PubMed ID: 23565664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of α‑ and β‑Klotho in urothelial carcinoma of the bladder.
    Hori S; Miyake M; Onishi S; Tatsumi Y; Morizawa Y; Nakai Y; Anai S; Tanaka N; Fujimoto K
    Oncol Rep; 2016 Oct; 36(4):2117-25. PubMed ID: 27573985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
    Zhu J; Lu Z; Ke M; Cai X
    Int Urol Nephrol; 2022 Jul; 54(7):1505-1512. PubMed ID: 35467245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and significance of CDC25B, PED/PEA-15 in esophageal carcinoma.
    Wang M; Zhu XY; Wang L; Lin Y
    Cancer Biother Radiopharm; 2015 Apr; 30(3):139-45. PubMed ID: 25775393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of mucin expression in urothelial bladder cancer.
    Stojnev S; Ristic-Petrovic A; Velickovic LJ; Krstic M; Bogdanovic D; Khanh do T; Ristic A; Conic I; Stefanovic V
    Int J Clin Exp Pathol; 2014; 7(8):4945-58. PubMed ID: 25197366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder.
    Dohn LH; Illemann M; Høyer-Hansen G; Christensen IJ; Hostmark J; Litlekalsoy J; von der Maase H; Pappot H; Laerum OD
    Urol Oncol; 2015 Apr; 33(4):165.e15-24. PubMed ID: 25575713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
    Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
    Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
    Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
    Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
    Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
    Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis.
    Hashmi AA; Hussain ZF; Irfan M; Edhi MM; Kanwal S; Faridi N; Khan A
    BMC Res Notes; 2018 Mar; 11(1):207. PubMed ID: 29587848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EIF2C, Dicer, and Drosha are up-regulated along tumor progression and associated with poor prognosis in bladder carcinoma.
    Zhang Z; Zhang G; Kong C; Bi J; Gong D; Yu X; Shi D; Zhan B; Ye P
    Tumour Biol; 2015 Jul; 36(7):5071-9. PubMed ID: 25656609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and Prognostic Potential of MicroRNA Maturation Regulators Drosha, AGO1 and AGO2 in Urothelial Carcinomas of the Bladder.
    Rabien A; Ratert N; Högner A; Erbersdobler A; Jung K; Ecke TH; Kilic E
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder.
    Du E; Zhang C; Qin Z; Yang K; Li C; Wang A; Zhang Z; Xu Y
    Urol Oncol; 2017 Apr; 35(4):152.e7-152.e12. PubMed ID: 28161324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
    Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
    PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
    Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
    Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study.
    Santi R; Cai T; Nobili S; Galli IC; Amorosi A; Comperat E; Nesi G
    Virchows Arch; 2018 Apr; 472(4):605-613. PubMed ID: 29525824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.